Long-term treatment with Ferriprox (deferiprone) safely and effectively reduced iron load in children and adults with blood transfusion-induced iron overload due…
Articles by Marta Figueiredo, PhD
Multiple daily doses of GBT601, Global Blood Therapeutics (GBT)’s experimental oral therapy for sickle cell disease (SCD), were generally well…
Exposure to systemic steroids — frequently used to treat asthma or ease inflammation — is significantly associated with a higher…
While most adolescent boys and young men with sickle cell disease (SCD) report wanting biological children in the future,…
A team of researchers has created the most comprehensive atlas, or roadmap, to date of each step of human blood…
Imara is discontinuing the clinical development of tovinontrine (IMR-687), its experimental oral therapy for sickle cell disease (SCD) and…
A team of international researchers has received a $3-million grant from the National Institutes of Health (NIH) to sequence…
Researchers have ruled out a phenomenon called clonal hematopoiesis as the potential cause of the increased risk of blood cancer…
Oxbryta (voxelotor) has become the first approved therapy in the European Union to target the underlying cause of sickle…
Blood vessel narrowing due to external or internal stimuli, and the resulting reduced blood flow, may be the main drivers…